View in EDS HTML Full Text PDF Full Text

Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients.

Saved in:
Bibliographic Details
Title: Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients.
Authors: Xu, Jianming1 (AUTHOR) jmxu2003@163.com, Cui, Jiuwei2 (AUTHOR), Jiang, Haiping3 (AUTHOR), Zeng, Yan4 (AUTHOR), Cong, Xiuyu4 (AUTHOR)
Source: Cancer Medicine. Apr2023, Vol. 12 Issue 7, p7762-7771. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.5532